Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
gene therapy
5
×
genentech
5
×
life sciences
national blog main
biotech
fda
national
national top stories
new york top stories
san francisco top stories
boston blog main
boston top stories
clinical trials
new york blog main
novartis
san diego blog main
san diego top stories
san francisco blog main
biogen
boulder/denver blog main
boulder/denver top stories
celgene
cell therapy
detroit blog main
detroit top stories
duchenne muscular dystrophy
eli lilly
glaxosmithkline
indiana blog main
indiana top stories
ipo
johnson & johnson
president trump
raleigh-durham blog main
raleigh-durham top stories
sarepta therapeutics
seattle blog main
seattle top stories
texas blog main
texas top stories
What
new
fda
bio
biotech
roundup
therapy
aiming
ambys
approved
atrophy
august
big
biopharma
busy
chemistry
cmc
congress
congressional
consistent
control
controls
crispr
daily
days
deadly
deal
debuted
decisions
devices
diseases
drug
drugs
ensure
evrysdi
executives
feud
formed
friday
future
gene
Language
unset
Current search:
genentech
×
" gene therapy "
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
3 years ago
FDA Official: New “Playbook” Needed for CMC Reviews of Gene Therapy Products
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?